Actively Recruiting

Age: 18Years +
All Genders
ID06680817

Real-World, Long-Term Data Collection to Gain Clinical Insights Into Faricimab for Neovascular Age-related Macular Degeneration and Diabetic Macular Edema

Led by Hoffmann-La Roche · Updated on 2026-05-11

850

Participants Needed

59

Research Sites

52 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying the use of faricimab in patients with neovascular age-related macular degeneration (nAMD) or diabetic macular edema (DME) affecting at least one eye. This observational study aims to evaluate the effectiveness, safety, treatment patterns, and health economics of faricimab in real-world clinical practice over a two-year follow-up period. The study includes patients both new to anti-VEGF treatment and those who have been previously treated with anti-VEGF therapies. Participants will receive faricimab as guided by local clinical practice and labeling. The study divides participants into two sub-cohorts based on their prior eye treatment history: those naive to anti-VEGF treatment and those previously treated. The study is designed to observe treatment regimens, dosing, and clinical outcomes in routine care settings without experimental interventions. During the study, participants will be monitored for changes in visual acuity and central subfield thickness at multiple time points up to 24 months. Researchers will collect data on injection frequency, treatment intervals, and any switch in treatment. Safety will be assessed by tracking ocular and non-ocular adverse events. The study emphasizes the collection of real-world clinical and economic data, following each patient for up to two years.

CONDITIONS

Brief Title

A Real-World Study to Gain Clinical Insights Into Faricimab (FaReal Study)

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients receiving faricimab according to local product labeling who started treatment at or within 3 months before consent
  • Patients with diabetic macular edema or neovascular age-related macular degeneration in at least one eye
  • Patients who have received at least one faricimab injection in the affected eye
  • Patients with available visual acuity and central subfield thickness data at baseline or within 4 months prior
Not Eligible

You will not qualify if you...

  • Participation in any investigational ophthalmology trial with investigational drugs or procedures within 28 days before consent
  • Concurrent participation in any interventional clinical study
  • Active eye inflammation or suspected/active eye infection in either eye
  • Participation in patient support programs such as market research, post-trial access, or compassionate use programs
  • Presence of non-ocular sight-threatening diseases affecting the primary study endpoint
  • Known hypersensitivity to faricimab or any of its components as per product label

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Up to 24 months

Participants receive Faricimab as per local clinical practice and labeling for neovascular age-related macular degeneration or diabetic macular edema.

Visits and injections occur according to routine clinical care over 24 months

Long-term Monitoring

Duration - Up to 24 months

Participants are monitored for visual acuity, central subfield thickness, treatment regimens, and adverse events during and after treatment.

Follow-up visits at approximately 3, 6, 12, and 24 months

Trial Site Locations

Total: 59 locations

1

LKH-Univ.Klinikum Graz

Graz, Austria, 8036

Actively Recruiting

2

Medizinische Universität Innsbruck

Innsbruck, Austria, 6020

Actively Recruiting

3

Kepler Universitätskliniken GmbH - Med Campus III

Linz, Austria, 4021

Actively Recruiting

4

Medizinische Universitat Wien

Vienna, Austria, 1090

Actively Recruiting

5

Hanusch Krankenhaus

Vienna, Austria, 1140

Actively Recruiting

6

Multiprofile Hospital for Active Treatment Trimontium OOD Plovdiv;Ophthalmology

Plovdiv, Bulgaria, 4000

Actively Recruiting

7

Eye Medical Center St. Luka

Plovdiv, Bulgaria, 4002

Actively Recruiting

8

Eye Diseases Medical Center LUX OPTICS;ophthalmology

Sofia, Bulgaria, 1164

Actively Recruiting

9

Tokuda Hospital

Sofia, Bulgaria, 1407

Actively Recruiting

10

Medical Clinic Svetlina

Sofia, Bulgaria

Actively Recruiting

11

Ambulatory for Group Practice for Specialized Medical Care in Ophthalmology - Dr. Grupchevi OOD;Ophthalmology

Varna, Bulgaria, 9010

Actively Recruiting

12

Krajska nemocnice Liberec a.s.

Liberec, Czechia, 460 63

Actively Recruiting

13

Klaudianova Nemocnice - Mlada Boleslav;Ophtalmology dpt

Mladá Boleslav, Czechia, 293 50

Actively Recruiting

14

Fakultni nemocnice Olomouc

Olomouc, Czechia, 779 00

Actively Recruiting

15

Faculty Hospital Ostrava

Ostrava, Czechia, 708 52

Actively Recruiting

16

Ustredni vojenska nemocnice - Vojenska fakultni nemocnice Praha

Prague, Czechia, 169 02

Actively Recruiting

17

Helsinki University Central Hospital

Helsinki, Finland, 00290

Actively Recruiting

18

Tampere University Hospital

Tampere, Finland, 33520

Actively Recruiting

19

General Hospital of Athens "Korgialeneio - Benakeio" Hellenic Red Cross

Athens, Greece, 115 26

Actively Recruiting

20

University General Hospital of Heraklion

Heraklion, Greece, 711 10

Actively Recruiting

21

University Hospital of Larissa

Larissa, Greece, 412 21

Actively Recruiting

22

Papageorgiou General Hospital of Thessaloniki

Thessaloniki, Greece, 564 29

Actively Recruiting

23

Erzsebet Furdo Gyogyaszati es Szurokozpont

Miskolc, Hungary, 3530

Actively Recruiting

24

Pecsi Tudomanyegyetem Klinikai Kozpont

Pécs, Hungary, 7623

Actively Recruiting

25

Szegedi Tudományegyetem ÁOK

Szeged, Hungary, 6720

Actively Recruiting

26

Mater Private Hospital

Dublin, Ireland, 7

Actively Recruiting

27

Bon Secours Hospital, Limerick

Limerick, Ireland, V94 HE2T

Actively Recruiting

28

Institute of Eye Surgery

Waterford, Ireland

Actively Recruiting

29

Barzilai Medical Center

Ashkelon, Israel, 7827800

Actively Recruiting

30

Shamir Medical Center Assaf Harofeh

Beer Jacob, Israel, 0073100

Actively Recruiting

31

Soroka university medical center

Beersheba, Israel, 8489501

Actively Recruiting

32

Carmel medical center

Haifa, Israel, 3436212

Actively Recruiting

33

Shaare Zedek Medical Center

Jerusalem, Israel, 91031

Actively Recruiting

34

Pauls Stradins Clinical University hospital

Riga, Latvia, 1002

Actively Recruiting

35

Riga East Clinical University hospital Bikernieki

Riga, Latvia, 1006

Actively Recruiting

36

Latvian-American Eye Center

Riga, Latvia, 1009

Actively Recruiting

37

Jeroen Bosch Ziekenhuis

's-Hertogenbosch, Netherlands, 5223 GZ

Actively Recruiting

38

ETZ Elisabeth

Tilburg, Netherlands, 5022 GC

Actively Recruiting

39

NZOZ Specjalistyczna Poradnia Lekarska Adrian Wojciech Przystupa

Bielsk Podlaski, Poland, 17-100

Actively Recruiting

40

Centrum Uslug Medycznych OKO-MED

Grudziądz, Poland, 86-300

Actively Recruiting

41

USK Nr 2 im. WAM w Lodzi, Centralny Szpital Weteranow

Lodz, Poland, 90-549

Actively Recruiting

42

Szpital Wojewodzki w Poznaniu

Poznan, Poland, 60-479

Actively Recruiting

43

Pomorski Uniwersytet Medyczny

Szczecin, Poland, 70-111

Actively Recruiting

44

Szpitale Pomorskie, Szpital Specjalistyczny im. F. Ceynowy

Wejherowo, Poland, 84-200

Actively Recruiting

45

Szpital Uniwersytecki im. Karola Marcinkowskiego w Zielonej Górze

Zielona Góra, Poland, 65-046

Actively Recruiting

46

Espaco Medico Coimbra

Coimbra, Portugal, 3030-163

Actively Recruiting

47

ULS Lisboa Ocidental - Hospital Egas Moniz

Lisbon, Portugal, 1349-019

Actively Recruiting

48

Hospital CUF Tejo

Lisbon, Portugal, 1350-352

Actively Recruiting

49

IMO - Instituto de Microcirurgia Ocular

Lisbon, Portugal, 1600-209

Actively Recruiting

50

Hospital de Sao Joao

Porto, Portugal, 4200-319

Actively Recruiting

51

Retina Clinic

Bucharest, Romania, 14146

Actively Recruiting

52

Clinica Bine

Bucharest, Romania

Actively Recruiting

53

Vista Vision

Bucurescti, Romania

Actively Recruiting

54

Centrul Oftalmologic Dr. Munteanu

Timișoara, Romania

Actively Recruiting

55

Nemocnica s poliklinikou Trebišov, a.s.

Trebišov, Slovakia, 075 01

Actively Recruiting

56

Fakultna nemocnica Trencin Ocna klinika

Trenčín, Slovakia, 911 71

Actively Recruiting

57

Fakultna nemocnica Trnava

Trnava, Slovakia, 917 75

Actively Recruiting

58

OFTAL s.r.o. Specializovana nemocnica v odbore oftalmologia Zvolen

Zvolen, Slovakia, 960 01

Actively Recruiting

59

General Hospital Murska Sobota

Murska Sobota, Slovenia, 9000

Actively Recruiting

Loading map...

Research Team

R

Reference Study ID Number: MR45586 https://forpatients.roche.com/

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

An Open-label Dose-escalation Study to Evaluate Safety, Prel...

Neovascular Age-related Macular Degeneration

Actively Recruiting

3 locations

Randomized, Double-blind Study Comparing Ranibizumab 10mg/ml...

Diabetic Macular Edema

Actively Recruiting

1 location

A Phase 1/2 Dose Escalation and Dose Expansion Study to Eval...

Neovascular Age-related Macular Degeneration

Actively Recruiting

18 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here